[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Ophthalmic Market: Focus on Glaucoma

January 2009 | 29 pages | ID: GFB89004CACEN
Koncept Analytics

US$ 800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Glaucoma is a type of disease that causes an irreversible blindness, if it is left undetected or untreated. Moreover there is no cure for glaucoma and regular medication is the only way to prevent blindness. In fact this is one of the main issues in the treatment of glaucoma, regularity in taking a proper medication course. Most people are not able to take the complete medication and the rate of medication regimen non-compliance is very high.

Nearly half of the people who are being prescribed for medication discontinue only after six months due to various reasons. Another inherent characteristic of glaucoma and a deterrent in proper treatment is that most of the times this disease goes unnoticed.

The market for ophthalmology and glaucoma consists of prescription or treatment and surgical or detection devices. The prescription or pharmaceuticals market is comparatively larger than the devices market both for ophthalmic and glaucoma. Contact Lenses is another significant market for ophthalmology. Region-wise US is the largest market for ophthalmic and glaucoma alike, and the global market is about 2-3 times that of the US market. Alcon, Allergan, Merck and Pfizer are main players.

The report focuses on glaucoma as a major ophthalmic market. The various aspects of glaucoma are discussed like glaucoma as a disease, types of glaucoma, and treatment of glaucoma. Global as well as US market size and forecasts are given for ophthalmic as well as glaucoma market. The market trends and the latest product developments in this field are also discussed. The major players operating in the market have also been profiled.

1. GLAUCOMA: AN INTRODUCTION

Types of Glaucoma
Open-Angle Glaucoma
Angle-Closure Glaucoma
Glaucoma Tests
Glaucoma Treatment
Laser Treatment
Surgical Treatment

2. OPHTHALMIC MARKET SIZE

2.1 Global Ophthalmic Market
  Market by Region
  Market Segments
2.2 US Ophthalmic Market
  Market Segments
2.3 Japanese Ophthalmic Market
  Growth Rate

3. GLAUCOMA MARKET SIZE

3.1 Global Glaucoma Market
  Market Value
  Market Share
3.2 US Glaucoma Market
  Market Value
  Market Share

4. MARKET DYNAMICS

4.1 Market Trends
  Growing Aging Population
  Irregularity in Adhering to Drug Treatment
  Unawareness about Suffering from Glaucoma
4.2 New Product Developments
  Punctal Plug Drug Delivery System
  NicOx/Pfizer’s Glaucoma Drug
  Alcon’s TRAVATANZ[TM] Approval in Japan
  Lexicon Pharmaceuticals Identifies New Drug Candidate
  Othera Pharmaceuticals Files Investigational New Drug

5. COMPANY PROFILES

5.1 Alcon
  Overview
  Business Strategies
  Reaching Out to Customers Globally
  Research Commitment to Ophthalmology
5.2 Allergan
  Overview
  Business Strategies
  Improving Operating Efficiency
  Diversity of Product Lines
5.3 Pfizer
  Overview
  Business Strategies
  Acquisitions, Licensing and Collaborations
  Cost Reduction Strategy
5.4 Merck & Co.
  Overview
  Business Strategies
  Focus on Customer Needs
  Business Efficiency

6. MARKET FORECAST

  Ophthalmic Market Forecast
  Glaucoma Market Forecast

LIST OF TABLES

Ophthalmic Market Segments
Region-wise CAGR of Global Prescription Ophthalmic Market (2005-10E)
Growth of Japanese Prescription Ophthalmic Market by Segments (2005-10E)

LIST OF CHARTS

Types of Glaucoma
Glaucoma Tests
Global Prescription Ophthalmic Market by Region (2000/05/10E)
Segment-wise Division of Regional Ophthalmic Market
Global Ophthalmic Market by Segments (2006-07)
US Ophthalmic Market by Segments (2004-2007)
Japanese Prescription Ophthalmic Market by Segments (2005/10E)
Global Glaucoma Market Size and Growth (2006-2008E)
Market Share of Leading Market Players (2007)
Glaucoma Market Share by Drug Types (2007)
US Glaucoma Market Value (2006-08)
Market Share of US Glaucoma Market (2007)
Sales Growth of Alcon (2003-07)
Sales Growth of Allergan (2003-07)
Sales Growth of Pfizer (2003-07)
Sales Growth of Merck (2003-07)
Global Ophthalmic Market Forecast (2008E-10E)
US Ophthalmic Market Forecast (2008-11E)
Global Glaucoma Market Forecast (2009-12E)
US Glaucoma Market Forecast (2009-12E)


More Publications